| Original language | English |
|---|---|
| Pages (from-to) | e890-e894 |
| Journal | Clinical Gastroenterology and Hepatology |
| Volume | 20 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1 Apr 2022 |
| Externally published | Yes |
ASJC Scopus subject areas
- Gastroenterology
- Hepatology
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Clinical Gastroenterology and Hepatology, Vol. 20, No. 4, 01.04.2022, p. e890-e894.
Research output: Contribution to journal › Short survey › peer-review
TY - JOUR
T1 - HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease
AU - Wieland, Amanda
AU - Etzion, Ohad
AU - Ali, Rabab O.
AU - Levy, Elliot
AU - Kleiner, David E.
AU - Helmke, Steve M.
AU - Heller, Theo
AU - Everson, Gregory T.
N1 - Funding Information: Funding Two cohorts comprised this study: an HVPG cohort and a dPP cohort. The HVPG cohort was studied under a Bioscience Discovery Evaluation Grant from the State of Colorado (POGG1 2015 0872). The dPP cohort was studied at the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases and the study was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, and the National Institutes of Health Clinical Center. The Agilent LCMS system used in this study was owned by HepQuant LLC, and samples for this study were analyzed for cholate and cholate isotopes in the laboratory of Gregory T. Everson at the University of Colorado Denver via an Equipment Use Agreement between HepQuant LLC and the University. Funding Information: Funding Two cohorts comprised this study: an HVPG cohort and a dPP cohort. The HVPG cohort was studied under a Bioscience Discovery Evaluation Grant from the State of Colorado (POGG1 2015 0872). The dPP cohort was studied at the National Institutes of Health , National Institute of Diabetes and Digestive and Kidney Diseases and the study was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases , National Cancer Institute , and the National Institutes of Health Clinical Center . The Agilent LCMS system used in this study was owned by HepQuant LLC, and samples for this study were analyzed for cholate and cholate isotopes in the laboratory of Gregory T. Everson at the University of Colorado Denver via an Equipment Use Agreement between HepQuant LLC and the University.
PY - 2022/4/1
Y1 - 2022/4/1
UR - http://www.scopus.com/inward/record.url?scp=85110559513&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2021.04.030
DO - 10.1016/j.cgh.2021.04.030
M3 - Short survey
C2 - 33895359
AN - SCOPUS:85110559513
SN - 1542-3565
VL - 20
SP - e890-e894
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 4
ER -